Ironwood Pharma (IRWD) Tops Q3 EPS by 29c

Ironwood Pharma (NASDAQ: IRWD) reported Q3 EPS of $0.42, $0.29 better than the analyst estimate of $0.13. Revenue for the quarter came in at $96.4 million versus the consensus estimate of $75.9 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• Wall Street scrambles to lift Micron price targets ahead of earnings
• Accenture tumbles 16% on guidance cut; announces Dragos, runZero, NetRise deals